Cite Filings / VNDA / 0001628280-26-010376

Feed Companies Filings Check

Sign in

8-K

Current Report

Vanda Pharmaceuticals Inc. Filed 2026-02-23 Acc 0001628280-26-010376

Other events

Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

8-K Current Report , vnda-20260220.htm

Around this filing

2026-03-10 8-K Regulation FD disclosure
2026-02-24 4 Director sold 30,000 shares at $8.03 ($240,900)
2026-02-23 8-K Other events
2026-02-23 144 Sale of Securities
2026-02-19 8-K Executive or director change
2026-02-19 4 SVP, Chief Marketing Officer acquired 125,000 shares (grant or award)
2026-02-19 4 SVP & General Counsel acquired 125,000 shares (grant or award)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading vnda-20260220.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…